ClearNote Health

Raised $52M in a Series D round, announced 27 May 2026.

Round

ClearNote Health raised $52 million in Series D financing and strengthened its leadership team to accelerate growth.

Amount
$52M
Stage
Series D
Announced
27 May 2026
Leads
Mattias Westman, a global, large, long-only active manager
Other investors
Sandy Weill, Stephen Quake, a large Seattle-based family office
Use of funds
Continued commercial expansion, clinical study execution, product development, and broader global access to its portfolio.
Total raised
$185M to date
Checked
Amount and date checked against the press source

Company

Develops early cancer detection products and services for patients and clinicians.

Based in
San Diego
Sector
Health
Website
clearnotehealth.com ↗

Founders

  • Stephen Quakeco-founder
  • Dave MullarkeyCEO

Sources and links

Source
ClearNote Health Secures $52 Million in Series D Financing and Strengthens Leadership Team to Accelerate Growt news.google.com
Website
clearnotehealth.com ↗
MediaBoost

Just raised?

MediaBoost gets your round in front of the press, future hires and your next investors.

Announce your round with MediaBoost